{"id":679295,"date":"2026-01-07T06:06:22","date_gmt":"2026-01-07T06:06:22","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/679295\/"},"modified":"2026-01-07T06:06:22","modified_gmt":"2026-01-07T06:06:22","slug":"amgen-to-acquire-oxford-spinout-dark-blue-tucking-in-a-preclinical-cancer-drug-endpoints-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/679295\/","title":{"rendered":"Amgen to acquire Oxford spinout Dark Blue, tucking in a preclinical cancer drug – Endpoints News"},"content":{"rendered":"
    \n
  1. Amgen to acquire Oxford spinout Dark Blue, tucking in a preclinical cancer drug<\/a>  Endpoints News<\/li>\n
  2. Amgen swoops on UK cancer biotech in deal worth up to $840mn<\/a>  Financial Times<\/li>\n
  3. AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE<\/a>  PR Newswire<\/li>\n
  4. Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs<\/a>  Fierce Biotech<\/li>\n
  5. Recon: Amgen to acquire Dark Blue for $480M; CDC slashes recommendations for childhood vaccines<\/a>  Regulatory Affairs Professionals Society | RAPS<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Amgen to acquire Oxford spinout Dark Blue, tucking in a preclinical cancer drug  Endpoints News Amgen swoops on UK…\n","protected":false},"author":2,"featured_media":679296,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[22194,151735,51,206140,206138,206139,982,206136,206137,206141,942,206135,15285,16,15],"class_list":{"0":"post-679295","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business","8":"tag-acute-myeloid-leukemia","9":"tag-amgen","10":"tag-business","11":"tag-cancer-pipeline","12":"tag-dark-blue-therapeutics","13":"tag-dbt-3757","14":"tag-deals","15":"tag-jay-bradner","16":"tag-oncology-acquisition","17":"tag-oxford-science-enterprises","18":"tag-oxford-university","19":"tag-protein-degradation","20":"tag-rd","21":"tag-uk","22":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115852318054595854","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/679295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=679295"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/679295\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/679296"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=679295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=679295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=679295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}